Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

Europe to provide Mozambique with $116 million in virus aid

Europe to provide Mozambique with $116 million in virus aid

THE European Union (EU) has agreed to provide Mozambique with 100 million euros ($116.30 million) in coronavirus-related aid, according to EU Ambassador Antonio Sanchez-Benedito Gaspar. The EU cut off direct budget support to Mozambique in 2016 after the country revealed the existence of hefty state-guaranteed loans that it had not previously disclosed. A number of other donors including the International Monetary Fund also halted aid to Mozambique. Sanchez-Benedito Gaspar told a press conference in the capital Maputo that the agreement had "different characteristics" to the direct budget support the EU used to provide and was focused specifically on helping with…
Read More
WHO chief says he is identified as contact of COVID-19 positive person

WHO chief says he is identified as contact of COVID-19 positive person

WORLD Health Organization Director-General Tedros Adhanom Ghebreyesus has revealed that he had been identified as a contact of someone who tested positive for COVID-19, but added that he was feeling well and did not have any symptoms. "I have been identified as a contact of someone who has tested positive for #COVID19. I am well and without symptoms but will self-quarantine over the coming days, in line with @WHO protocols, and work from home," Tedros said in a tweet. - Thomson Reuters Foundation.
Read More
Nigeria needs innovation and science investment to help control COVID-19

Nigeria needs innovation and science investment to help control COVID-19

NIGERIA, like other African countries, wasn’t spared from the spread of the coronavirus pandemic. To overcome this challenge, countries have been advised to keep testing, treating and isolating to reduce infections. CHRISTIAN HAPPI, Professor of Molecular Biology and Genomics, Redeemer's University IFEYINWA ANIEBO, Research fellow (Harvard Takemi fellow), Harvard T.H. Chan School of Public Health Nigeria has been expanding its capacity to test. The country’s laboratories can carry out about 18,000 tests per million daily, but this can be improved. The country ought to be doing about 40,000 - 50,000 tests daily. Nigeria successfully controlled Ebola and is applying some…
Read More
Can solar fridges help deliver a COVID-19 vaccine to Africans?

Can solar fridges help deliver a COVID-19 vaccine to Africans?

PEYTON FLEMING DOZENS of children at a clinic in North Kivu, on the eastern border of the Democratic Republic of Congo (DRC), received a measles vaccine in May, made possible by a quiet revolution in refrigeration that keeps vaccines cold, even in places without reliable electric power. The "solar direct-drive" refrigerators – plain, box-like coolers that do not require fuel or batteries - have helped boost child vaccinations in DRC's poorest rural provinces by 50% in the past year, according to global vaccine alliance Gavi. That has helped cut child mortality in DRC to half of what it was two…
Read More
Mozambique’s health minister tests positive for coronavirus

Mozambique’s health minister tests positive for coronavirus

MOZAMBIQUE’S health minister, Armindo Tiago, has tested positive for COVID-19, he said in a statement, adding that he was well, however, showing no symptoms, and in isolation at home. "I am infected, but not sick," Tiago said. "No one in this world can say that they are immune to the new coronavirus." The southeast African nation has reported 10,258 infections, with 73 deaths.
Read More
J&J says review of illness that led to coronavirus vaccine trial pause could take days

J&J says review of illness that led to coronavirus vaccine trial pause could take days

CARL O’DONNELL and MANAS MISHRA  JOHNSON & Johnson has announced that it would take at least a few days for an independent safety panel to evaluate an unexplained illness of a study participant that led to a pause in the company's COVID-19 vaccine trial. J&J shares fell more than 2% following news of the pause and safety review. Rival AstraZeneca Plc's U.S. trial for its coronavirus vaccine candidate - which uses a similar technology - has remained on hold for more than a month after a participant in the company's UK trial fell ill. J&J, whose vaccine effort is among…
Read More
Pandemic can be overcome quickly with right tools – WHO

Pandemic can be overcome quickly with right tools – WHO

THE global COVID-19 pandemic can be overcome quickly if countries use the right tools, the head of the World Health Organisation has said, but warned that if those tools were not used it would remain for a long time. "If we use the tools we have at hand properly, we can end it soon," WHO Director-General Dr Tedros Adhanom Ghebreyesus said during the Financial Times' online Africa summit, adding a vaccine was expected late 2020 or early next year. "If we don't use the tools we have at hand properly, then it could linger with us, it could stay with…
Read More
Pandemic adds to war in keeping Libyan children out of school

Pandemic adds to war in keeping Libyan children out of school

THEIR young lives already disrupted by war, Libyan school children face even bigger obstacles to their education during the global pandemic than young people elsewhere. With the number of cases surging unhindered across the North African country schools have tried different tactics from opening outside to seeking donations for extra disinfectants and facemasks to allow teaching indoors. However, even those who have had no teaching for six months, or much prospect of it during the rest of this year, will have to pass an exam in order to progress to the next grade, the authorities have said. "Students did not…
Read More
‘Corona carriers’: Stigma halts medication and meet-ups for HIV+ Malawians

‘Corona carriers’: Stigma halts medication and meet-ups for HIV+ Malawians

CHARLES PENSULO  MALAWIAN student Kondwani has fought against the stigma of being HIV-positive for most of his life, but COVID-19 has reignited old prejudices and given rise to a new term of abuse - "corona carrier". A widely held misconception that HIV-positive people are at high risk of catching the coronavirus is fueling discrimination and making it harder for them to access the medical care they need, health activists in the southern African country said. Kondwani, 24, said it was also spreading anxiety among the 1.1 million people who live with HIV in Malawi - which has one of the…
Read More
UK study tests if BCG vaccine protects against COVID

UK study tests if BCG vaccine protects against COVID

THE widely used BCG tuberculosis vaccine will be tested on frontline care workers in Britain for its effectiveness against COVID-19, researchers running the UK arm of a global trial said. Bacillus Calmette-Guérin (BCG) vaccine, used to protect against tuberculosis, induces a broad innate immune-system response and has been shown to protect against infection or severe illness with other respiratory pathogens. "BCG has been shown to boost immunity in a generalised way, which may offer some protection against COVID-19," Professor John Campbell, of the University of Exeter Medical School, said. "We are seeking to establish whether the BCG vaccine could help…
Read More